Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Patient’s and physician’s awareness of kidney disease in coronary heart disease patients – a cross-sectional analysis of the German subset of the EUROASPIRE IV survey

Authors: Martin Wagner, Christoph Wanner, Martin Schich, Kornelia Kotseva, David Wood, Katrin Hartmann, Georg Fette, Viktoria Rücker, Mehmet Oezkur, Stefan Störk, Peter U. Heuschmann

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Chronic kidney disease (CKD) is a common comorbid condition in coronary heart disease (CHD). CKD predisposes the patient to acute kidney injury (AKI) during hospitalization. Data on awareness of kidney dysfunction among CHD patients and their treating physicians are lacking. In the current cross-sectional analysis of the German EUROASPIRE IV sample we aimed to investigate the physician’s awareness of kidney disease of patients hospitalized for CHD and also the patient’s awareness of CKD in a study visit following hospital discharge.

Methods

All serum creatinine (SCr) values measured during the hospital stay were used to describe impaired kidney function (eGFRCKD-EPI < 60 ml/min/1.73m2) at admission, discharge and episodes of AKI (KDIGO definition). Information extracted from hospital discharge letters and correct ICD coding for kidney disease was studied as a surrogate of physician’s awareness of kidney disease. All patients were interrogated 0.5 to 3 years after hospital discharge, whether they had ever been told about kidney disease by a physician.

Results

Of the 536 patients, 32% had evidence for acute or chronic kidney disease during the index hospital stay. Either condition was mentioned in the discharge letter in 22%, and 72% were correctly coded according to ICD-10. At the study visit in the outpatient setting 35% had impaired kidney function. Of 158 patients with kidney disease, 54 (34%) were aware of CKD. Determinants of patient’s awareness were severity of CKD (OReGFR 0.94; 95%CI 0.92–0.96), obesity (OR 1.97; 1.07–3.64), history of heart failure (OR 1.99; 1.00–3.97), and mentioning of kidney disease in the index event’s hospital discharge letter (OR 5.51; 2.35–12.9).

Conclusions

Although CKD is frequent in CHD, only one third of patients is aware of this condition. Patient’s awareness was associated with kidney disease being mentioned in the hospital discharge letter. Future studies should examine how raising physician’s awareness for kidney dysfunction may improve patient’s awareness of CKD.
Literature
1.
go back to reference Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285–95.CrossRefPubMed Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351(13):1285–95.CrossRefPubMed
2.
go back to reference Azar RR, Prpic R, Ho KK, et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol. 2000;86(5):485–9.CrossRefPubMed Azar RR, Prpic R, Ho KK, et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol. 2000;86(5):485–9.CrossRefPubMed
3.
go back to reference Bruck K, Stel VS, Gambaro G, et al. CKD prevalence varies across the european general population. J Am Soc Nephrol. 2016;27(7):2135–47.CrossRefPubMed Bruck K, Stel VS, Gambaro G, et al. CKD prevalence varies across the european general population. J Am Soc Nephrol. 2016;27(7):2135–47.CrossRefPubMed
4.
go back to reference Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.CrossRefPubMed Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.CrossRefPubMed
5.
go back to reference Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.CrossRefPubMed Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.CrossRefPubMed
6.
go back to reference Ix JH, Mercado N, Shlipak MG, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the arterial revascularization therapies study (ARTS). Am Heart J. 2005;149(3):512–9.CrossRefPubMed Ix JH, Mercado N, Shlipak MG, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the arterial revascularization therapies study (ARTS). Am Heart J. 2005;149(3):512–9.CrossRefPubMed
7.
go back to reference Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.CrossRefPubMed Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–47.CrossRefPubMed
8.
go back to reference Di Angelantonio E, Chowdhury R, Sarwar N, et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ. 2010;c4986:341. Di Angelantonio E, Chowdhury R, Sarwar N, et al. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ. 2010;c4986:341.
9.
go back to reference Tonelli M, Jose P, Curhan G, et al. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ. 2006;332(7555):1426.CrossRefPubMedPubMedCentral Tonelli M, Jose P, Curhan G, et al. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ. 2006;332(7555):1426.CrossRefPubMedPubMedCentral
10.
go back to reference van Domburg RT, Hoeks SE, Welten GM, et al. Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol. 2008;19(1):158–63.CrossRefPubMedPubMedCentral van Domburg RT, Hoeks SE, Welten GM, et al. Renal insufficiency and mortality in patients with known or suspected coronary artery disease. J Am Soc Nephrol. 2008;19(1):158–63.CrossRefPubMedPubMedCentral
12.
go back to reference Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1–184.CrossRefPubMed Black C, Sharma P, Scotland G, et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess. 2010;14(21):1–184.CrossRefPubMed
13.
go back to reference Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553–9.CrossRefPubMed Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553–9.CrossRefPubMed
14.
go back to reference Boulware LE, Carson KA, Troll MU, et al. Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. J Gen Intern Med. 2009;24(10):1123–9.CrossRefPubMedPubMedCentral Boulware LE, Carson KA, Troll MU, et al. Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. J Gen Intern Med. 2009;24(10):1123–9.CrossRefPubMedPubMedCentral
15.
go back to reference Plantinga LC, Boulware LE, Coresh J, et al. Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med. 2008;168(20):2268–75.CrossRefPubMedPubMedCentral Plantinga LC, Boulware LE, Coresh J, et al. Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med. 2008;168(20):2268–75.CrossRefPubMedPubMedCentral
16.
go back to reference Alm-Roijer C, Stagmo M, Uden G, et al. Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease. Eur J Cardiovasc Nurs. 2004;3(4):321–30.CrossRefPubMed Alm-Roijer C, Stagmo M, Uden G, et al. Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease. Eur J Cardiovasc Nurs. 2004;3(4):321–30.CrossRefPubMed
17.
go back to reference Whaley-Connell A, Sowers JR, McCullough PA, et al. Diabetes mellitus and CKD awareness: the kidney early evaluation program (KEEP) and National Health and nutrition examination survey (NHANES). Am J Kidney Dis. 2009;53(4 Suppl 4):S11–21.CrossRefPubMed Whaley-Connell A, Sowers JR, McCullough PA, et al. Diabetes mellitus and CKD awareness: the kidney early evaluation program (KEEP) and National Health and nutrition examination survey (NHANES). Am J Kidney Dis. 2009;53(4 Suppl 4):S11–21.CrossRefPubMed
18.
go back to reference Kotseva K, De Bacquer D, Jennings C, et al. Adverse lifestyle trends counter improvements in cardiovascular risk factor management in coronary patients. J Am Coll Cardiol. 2015;66(14):1634–6.CrossRefPubMed Kotseva K, De Bacquer D, Jennings C, et al. Adverse lifestyle trends counter improvements in cardiovascular risk factor management in coronary patients. J Am Coll Cardiol. 2015;66(14):1634–6.CrossRefPubMed
19.
go back to reference Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373(9667):929–40.CrossRefPubMed Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009;373(9667):929–40.CrossRefPubMed
20.
go back to reference Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23(6):636–48.CrossRefPubMed Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23(6):636–48.CrossRefPubMed
21.
go back to reference McClellan WM, Newsome BB, McClure LA, et al. Chronic kidney disease is often unrecognized among patients with coronary heart disease: the REGARDS cohort study. Am J Nephrol. 2009;29(1):10–7.CrossRefPubMed McClellan WM, Newsome BB, McClure LA, et al. Chronic kidney disease is often unrecognized among patients with coronary heart disease: the REGARDS cohort study. Am J Nephrol. 2009;29(1):10–7.CrossRefPubMed
22.
go back to reference Middleton ET, Morice AH. Breath carbon monoxide as an indication of smoking habit. Chest. 2000;117(3):758–63.CrossRefPubMed Middleton ET, Morice AH. Breath carbon monoxide as an indication of smoking habit. Chest. 2000;117(3):758–63.CrossRefPubMed
23.
go back to reference Kaspar M, Ertl M, Fette G, et al. Data linkage from clinical to study databases via an R data warehouse user interface. Experiences from a large clinical follow-up study. Methods Inf Med. 2016;55(4):381–6.CrossRefPubMed Kaspar M, Ertl M, Fette G, et al. Data linkage from clinical to study databases via an R data warehouse user interface. Experiences from a large clinical follow-up study. Methods Inf Med. 2016;55(4):381–6.CrossRefPubMed
24.
go back to reference Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter. 2013;(Suppl 3):1–150. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Inter. 2013;(Suppl 3):1–150.
25.
go back to reference Kidney Disease Improving Global Outcomes (KDIGO) AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter. 2012;(Suppl 2):1–138. Kidney Disease Improving Global Outcomes (KDIGO) AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Inter. 2012;(Suppl 2):1–138.
26.
go back to reference Kintscher U, Böhm M, Goss F, et al. Kommentar zur 2013-ESH/ESC-Leitlinie zum management der arteriellen Hypertonie. Kardiologe. 2014;8(3):223–30.CrossRef Kintscher U, Böhm M, Goss F, et al. Kommentar zur 2013-ESH/ESC-Leitlinie zum management der arteriellen Hypertonie. Kardiologe. 2014;8(3):223–30.CrossRef
27.
go back to reference Hsu CC, Hwang SJ, Wen CP, et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006;48(5):727–38.CrossRefPubMed Hsu CC, Hwang SJ, Wen CP, et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006;48(5):727–38.CrossRefPubMed
28.
go back to reference Tuot DS, Plantinga LC, Judd SE, et al. Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. 2013;37(2):135–43.CrossRefPubMedPubMedCentral Tuot DS, Plantinga LC, Judd SE, et al. Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. 2013;37(2):135–43.CrossRefPubMedPubMedCentral
29.
go back to reference McIntyre NJ, Fluck R, McIntyre C, et al. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Brit J Gen Pract. 2012;62(597):e227–32.CrossRef McIntyre NJ, Fluck R, McIntyre C, et al. Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Brit J Gen Pract. 2012;62(597):e227–32.CrossRef
30.
go back to reference Wright Nunes JA, Wallston KA, Eden SK, et al. Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int. 2011;80(12):1344–51.CrossRefPubMed Wright Nunes JA, Wallston KA, Eden SK, et al. Associations among perceived and objective disease knowledge and satisfaction with physician communication in patients with chronic kidney disease. Kidney Int. 2011;80(12):1344–51.CrossRefPubMed
31.
32.
go back to reference Cavanaugh KL, Merkin SS, Plantinga LC, et al. Accuracy of patients’ reports of comorbid disease and their association with mortality in ESRD. Am J Kidney Dis. 2008;52(1):118–27.CrossRefPubMedPubMedCentral Cavanaugh KL, Merkin SS, Plantinga LC, et al. Accuracy of patients’ reports of comorbid disease and their association with mortality in ESRD. Am J Kidney Dis. 2008;52(1):118–27.CrossRefPubMedPubMedCentral
33.
go back to reference Jafar TH, Allen JC, Jehan I, et al. Health education and general practitioner training in hypertension management: long-term effects on kidney function. Clin J Am Soc Nephrol. 2016;11(6):1044–53.CrossRefPubMedPubMedCentral Jafar TH, Allen JC, Jehan I, et al. Health education and general practitioner training in hypertension management: long-term effects on kidney function. Clin J Am Soc Nephrol. 2016;11(6):1044–53.CrossRefPubMedPubMedCentral
34.
go back to reference Hare DL, Toukhsati SR, Johansson P, et al. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365–72.CrossRefPubMed Hare DL, Toukhsati SR, Johansson P, et al. Depression and cardiovascular disease: a clinical review. Eur Heart J. 2014;35(21):1365–72.CrossRefPubMed
35.
go back to reference Tsai YC, Chiu YW, Hung CC, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60(1):54–61.CrossRefPubMed Tsai YC, Chiu YW, Hung CC, et al. Association of symptoms of depression with progression of CKD. Am J Kidney Dis. 2012;60(1):54–61.CrossRefPubMed
36.
go back to reference Jones C, Roderick P, Harris S, et al. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant. 2006;21(8):2133–43.CrossRefPubMed Jones C, Roderick P, Harris S, et al. Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant. 2006;21(8):2133–43.CrossRefPubMed
37.
go back to reference Jungers P, Massy ZA, Nguyen-Khoa T, et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant. 2001;16(12):2357–64.CrossRefPubMed Jungers P, Massy ZA, Nguyen-Khoa T, et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant. 2001;16(12):2357–64.CrossRefPubMed
38.
go back to reference Girndt M, Trocchi P, Scheidt-Nave C, et al. The prevalence of renal failure. Results from the German health interview and examination survey for adults, 2008-2011 (DEGS1). Dtsch Arztebl Int. 2016;113(6):85–91.PubMedPubMedCentral Girndt M, Trocchi P, Scheidt-Nave C, et al. The prevalence of renal failure. Results from the German health interview and examination survey for adults, 2008-2011 (DEGS1). Dtsch Arztebl Int. 2016;113(6):85–91.PubMedPubMedCentral
39.
go back to reference Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.CrossRef Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073–81.CrossRef
40.
go back to reference Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–39.CrossRefPubMed Ronco C, Haapio M, House AA, et al. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527–39.CrossRefPubMed
41.
go back to reference Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27(3 Suppl):S110–27.CrossRefPubMed Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27(3 Suppl):S110–27.CrossRefPubMed
42.
go back to reference Bohlouli B, Tonelli M, Jackson T, et al. Risk of hospital-acquired complications in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2016;11(6):956–63.CrossRefPubMedPubMedCentral Bohlouli B, Tonelli M, Jackson T, et al. Risk of hospital-acquired complications in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2016;11(6):956–63.CrossRefPubMedPubMedCentral
43.
go back to reference Pinkau T, Mann JF, Ndrepepa G, et al. Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kidney Dis. 2004;44(4):627–35.CrossRefPubMed Pinkau T, Mann JF, Ndrepepa G, et al. Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kidney Dis. 2004;44(4):627–35.CrossRefPubMed
44.
go back to reference Odutayo A, Wong CX, Farkouh M, et al. AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol. 2017;28(1):377–87.CrossRefPubMed Odutayo A, Wong CX, Farkouh M, et al. AKI and long-term risk for cardiovascular events and mortality. J Am Soc Nephrol. 2017;28(1):377–87.CrossRefPubMed
45.
go back to reference Accetta NA, Gladstone EH, DiSogra C, et al. Prevalence of estimated GFR reporting among US clinical laboratories. Am J Kidney Dis. 2008;52(4):778–87.CrossRefPubMedPubMedCentral Accetta NA, Gladstone EH, DiSogra C, et al. Prevalence of estimated GFR reporting among US clinical laboratories. Am J Kidney Dis. 2008;52(4):778–87.CrossRefPubMedPubMedCentral
46.
go back to reference Task Force Members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.CrossRef Task Force Members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.CrossRef
47.
go back to reference Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–9.CrossRefPubMedPubMedCentral Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–9.CrossRefPubMedPubMedCentral
48.
go back to reference Levey AS, Stevens LA. Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010;55(4):622–7.CrossRefPubMedPubMedCentral Levey AS, Stevens LA. Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis. 2010;55(4):622–7.CrossRefPubMedPubMedCentral
Metadata
Title
Patient’s and physician’s awareness of kidney disease in coronary heart disease patients – a cross-sectional analysis of the German subset of the EUROASPIRE IV survey
Authors
Martin Wagner
Christoph Wanner
Martin Schich
Kornelia Kotseva
David Wood
Katrin Hartmann
Georg Fette
Viktoria Rücker
Mehmet Oezkur
Stefan Störk
Peter U. Heuschmann
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0730-3

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue